RetiSpec: Funding, Investors & Team (Aug 2026)
RetiSpec is creating a non-intrusive technology for examining the eyes, which will enable the identification of indications of the onset of Alzheimer's Disease several years before symptoms become evident. This will enable medical professionals to intervene with new treatments in the initial stages when there is a possibility of making a difference in the progression of the illness.
RetiSpec has raised $10.0M across 2 funding rounds on record, the most recent a Series A of $10.0M announced in Jul 2024.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
RetiSpec Company Profile and Key Stats
Latest funding round on record: Jul 2024.
RetiSpec Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
RetiSpec announced an undisclosed round in Apr 2023; the amount was not disclosed.
1.3 years later, a Series A of $10.0M was announced in Jul 2024.
RetiSpec Founders and Leadership Team
Contact details for the RetiSpec team: 1 of 1 has an email address on file.
Start 14-day free trial →RetiSpec Funding Compared to Other Health Care Startups
RetiSpec's latest round of $10.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like RetiSpec in Health Care and Toronto
Companies Similar to RetiSpec
Cuffway develops medical devices for automated, real-time regulation of endotracheal tube cuff pressure to…
Principal Technologies is a Canadian business that invests in healthcare technologies.
Developing Life Altering Treatments for Patients Suffering from Rare Chronic Diseases.
Optimi Health is a supplier of natural, pharmaceutical-grade psilocybin and synthetic psychedelic compounds.…
Kare specializes in the research, development, and commercialization of catalysts, precursors, and industrial…
Synakis patented a biodegradable hydrogel vitreous substitute that is injectable, non-cytotoxic in vitro and…
Canadian Coalition for Seniors' Mental Health works to promote seniors' mental health by connecting people,…
Jack.org is a charitable group that instructs and strengthens young pioneers to change the field of mental…
Aplantex produces plant-based active compounds for application in the pharma, cosmetics, and agri-food…
Perimeter Medical Imaging is a medical technology company driven to transform cancer surgery with ultra-high…
Leveljump Healthcare offers radiology solutions for hospitals, emergency rooms, and private clinics. They…
Psyched Wellness is a Canadian-based company improving the health and wellness of millions with high-quality…
RetiSpec Funding FAQs
What does RetiSpec do?
RetiSpec is creating a non-intrusive technology for examining the eyes, which will enable the identification of indications of the onset of Alzheimer's Disease several years before symptoms become evident. This will enable medical professionals to intervene with new treatments in the initial stages when there is a possibility of making a difference in the progression of the illness.
How much funding has RetiSpec raised?
RetiSpec has raised $10.0M across 2 rounds on record. The most recent is a Series A of $10.0M announced in Jul 2024.
When did RetiSpec last raise funding?
RetiSpec's most recent funding round on record is a Series A of $10.0M, announced in Jul 2024.
Who founded RetiSpec?
FundedIQ lists Roy Kirshon (Founder) at RetiSpec.
Where is RetiSpec headquartered?
RetiSpec is based in Toronto, Ontario, Canada.
How many employees does RetiSpec have?
RetiSpec is in the 1-10 employee band.
How does RetiSpec's funding compare to other Health Care startups?
RetiSpec's latest round of $10.0M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's RetiSpec Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for RetiSpec is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.